- 恒指
- 26,232
- +82
- 大市成交 2,451億
- 即時石四藥集團
- 3.0500.000 (0.000%)
- 08/01/2026
- 曲繼廣
- 1113(L)
- +1,486,000(L)
- HKD3.043(L)
- 1,232,836,000(L)
- 41.77
- 07/01/2026
- 曲繼廣
- 1113(L)
- +1,128,000(L)
- HKD3.020(L)
- 1,231,350,000(L)
- 41.72
- 06/01/2026
- 曲繼廣
- 1113(L)
- +1,500,000(L)
- HKD2.980(L)
- 1,230,222,000(L)
- 41.68
- 05/01/2026
- 曲繼廣
- 1113(L)
- +1,100,000(L)
- HKD2.898(L)
- 1,228,722,000(L)
- 41.63
- 22/12/2025
- UBS Group AG
- 1402(S)
- +170,000(S)
- 185,116,122(L)
29,081,222(S)
- 6.37
1.00
- 01/12/2025
- 曲繼廣
- 1113(L)
- +1,000,000(L)
- HKD3.101(L)
- 1,227,622,000(L)
- 41.60
- 01/12/2025
- China Pharmaceutical Company Limited
- 1710(L)
- +1,000,000(L)
- HKD3.101(L)
- 890,204,000(L)
- 30.17
- 28/11/2025
- 曲繼廣
- 1113(L)
- +600,000(L)
- HKD3.058(L)
- 1,226,622,000(L)
- 41.56
- 28/11/2025
- China Pharmaceutical Company Limited
- 1710(L)
- +600,000(L)
- HKD3.058(L)
- 889,204,000(L)
- 30.13
- 26/11/2025
- 曲繼廣
- 1113(L)
- +2,300,000(L)
- HKD3.060(L)
- 1,226,022,000(L)
- 41.54
- 26/11/2025
- China Pharmaceutical Company Limited
- 1710(L)
- +2,300,000(L)
- HKD3.060(L)
- 888,604,000(L)
- 30.11
- 25/11/2025
- 曲繼廣
- 1113(L)
- +2,000,000(L)
- HKD2.983(L)
- 1,223,722,000(L)
- 41.46
- 24/11/2025
- UBS Group AG
- 1313(L)
- 900,000(L)
- 184,658,154(L)
- 6.35
- 31/10/2025
- UBS Group AG
- 1502(S)
- -1,400,000(S)
- 187,397,222(L)
28,528,669(S)
- 6.45
0.98
- 31/10/2025
- 四川科倫藥業股份有限公司
- 1101(L)
- +1,128,000(L)
- HKD3.098(L)
- 679,558,000(L)
- 23.03
- 30/10/2025
- 曲繼廣
- 1113(L)
- +5,000,000(L)
- HKD3.083(L)
- 1,221,722,000(L)
- 41.39
- 28/10/2025
- UBS Group AG
- 1402(S)
- +882,468(S)
- 188,491,222(L)
29,546,669(S)
- 6.47
1.01
- 27/10/2025
- UBS Group AG
- 1502(S)
- -700,000(S)
- 187,557,350(L)
28,582,797(S)
- 6.44
0.98
- 21/10/2025
- 曲繼廣
- 1113(L)
- +2,100,000(L)
- HKD2.896(L)
- 1,216,722,000(L)
- 41.22
- 15/10/2025
- UBS Group AG
- 1402(S)
- +1,400,000(S)
- 189,409,222(L)
29,850,669(S)
- 6.50
1.02